GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Huakang Biomedical Holdings Co Ltd (HKSE:08622) » Definitions » Days Payable

Huakang Biomedical Holdings Co (HKSE:08622) Days Payable : 23.94 (As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Huakang Biomedical Holdings Co Days Payable?

Huakang Biomedical Holdings Co's average Accounts Payable for the three months ended in Dec. 2023 was HK$0.70 Mil. Huakang Biomedical Holdings Co's Cost of Goods Sold for the three months ended in Dec. 2023 was HK$2.66 Mil. Hence, Huakang Biomedical Holdings Co's Days Payable for the three months ended in Dec. 2023 was 23.94.

The historical rank and industry rank for Huakang Biomedical Holdings Co's Days Payable or its related term are showing as below:

HKSE:08622' s Days Payable Range Over the Past 10 Years
Min: 31.74   Med: 45.69   Max: 60.76
Current: 35.1

During the past 9 years, Huakang Biomedical Holdings Co's highest Days Payable was 60.76. The lowest was 31.74. And the median was 45.69.

HKSE:08622's Days Payable is ranked worse than
86.84% of 973 companies
in the Drug Manufacturers industry
Industry Median: 88.69 vs HKSE:08622: 35.10

Huakang Biomedical Holdings Co's Days Payable declined from Dec. 2022 (31.86) to Dec. 2023 (23.94). It may suggest that Huakang Biomedical Holdings Co accelerated paying its suppliers.


Huakang Biomedical Holdings Co Days Payable Historical Data

The historical data trend for Huakang Biomedical Holdings Co's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Huakang Biomedical Holdings Co Days Payable Chart

Huakang Biomedical Holdings Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Payable
Get a 7-Day Free Trial Premium Member Only 47.58 60.76 39.96 35.03 31.74

Huakang Biomedical Holdings Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.86 39.39 44.25 42.14 23.94

Competitive Comparison of Huakang Biomedical Holdings Co's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Huakang Biomedical Holdings Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Huakang Biomedical Holdings Co's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Huakang Biomedical Holdings Co's Days Payable distribution charts can be found below:

* The bar in red indicates where Huakang Biomedical Holdings Co's Days Payable falls into.



Huakang Biomedical Holdings Co Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Huakang Biomedical Holdings Co's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

Days Payable (A: Dec. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2022 ) + Accounts Payable (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (0.926 + 0.698) / 2 ) / 9.337*365
=0.812 / 9.337*365
=31.74

Huakang Biomedical Holdings Co's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

Days Payable (Q: Dec. 2023 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Sep. 2023 ) + Accounts Payable (Q: Dec. 2023 )) / count ) / Cost of Goods Sold (Q: Dec. 2023 )*Days in Period
=( (0 + 0.698) / 1 ) / 2.661*365 / 4
=0.698 / 2.661*365 / 4
=23.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Huakang Biomedical Holdings Co Days Payable Related Terms

Thank you for viewing the detailed overview of Huakang Biomedical Holdings Co's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Huakang Biomedical Holdings Co (HKSE:08622) Business Description

Traded in Other Exchanges
N/A
Address
No.16 Yinkui Road, 1-3 floor, Building D, Shenzhen Junxuan, Kui Xin Community, Kui Chong Office, Dapeng New District, Shenzhen, CHN
Huakang Biomedical Holdings Co Ltd is engaged in the research, development, manufacture, marketing, and sale of in-vitro diagnostic reagents and auxiliary reproductive supplies and equipment in China. Its products include Male fertility IVD reagents; Parasite antibody detection reagents; EBV antibody detection reagents; and Auxiliary reproductive supplies and equipment. The group has also diversified its business to vitamins and supplements products for the markets in the PRC, Hong Kong, and overseas.
Executives
Tgga, Llc 2106 Person having a security interest in shares
Lau Lai Yee 2201 Interest of corporation controlled by you
Kokusai Resources Company Limited 2101 Beneficial owner
Zhang Shuguang 2101 Beneficial owner
Crystal Grant Limited 2101 Beneficial owner
Chang Yim Yang 2401 A concert party to an agreement to buy shares
Ever Charming Inc. 2101 Beneficial owner
Wealthy Pride Investment Limited 2101 Beneficial owner

Huakang Biomedical Holdings Co (HKSE:08622) Headlines

No Headlines